Polynucleotides are anionic macromolecules which are expected to transfer into the targeted cells through specific uptake mechanisms. So, we developed polynucleotides coating complexes of plasmid DNA (pDNA) and polyethylenimine (PEI) for a secure and efficient gene delivery system and evaluated their usefulness. Polyadenylic acid (polyA), polyuridylic acid (polyU), polycytidylic acid (polyC), and polyguanylic acid (polyG) were examined as the coating materials. pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes formed nanoparticles with a negative surface charge although pDNA/PEI/polyG was aggregated. The pDNA/PEI/polyC complex showed high transgene efficiency in B16-F10 cells although there was little efficiency in pDNA/PEI/polyA and pDNA/PEI/polyU complexes. An inhibition study strongly indicated the specific uptake mechanism of pDNA/PEI/polyC complex.
Introduction
Gene therapy is expected to be an effective method to treat cancer, infectious diseases, innate immunodeficiency, and cardiovascular diseases (Cavazzana-Calvo et al., 2012; Zarogouldis et al., 2012; Su et al., 2012) . Nucleic acids such as plasmid DNA (pDNA), antisense oligonucleotide, and small interfering RNA (siRNA) are used as therapeutic agents. The success of gene therapy highly depends on the development of an effective and secure gene delivery system, but there are many obstacles to the delivery of naked nucleic acids, such as rapid enzymatic degradation, rapid elimination via the kidney, and poor cellular uptake because of their large molecules and anionic charge, which govern biodistribution in the body (Nishikawa et al., 2005; Sato et al., 2007) . In order to overcome these obstacles, a number of viral and non-viral vectors for nucleic acids have been developed for targeting cells and tissues through specific mechanisms (Nishikawa et al., 2005; Kurosaki et al., 2011; Corey, 2007; Tagalakis et al., 2011; Kawakami et al., 2000) . Non-viral vectors for gene delivery have emerged as a promising alternative to viral vectors, because non-viral vectors have advantages such as much lower immunotoxicity, a clear structure, and easy modeling (Liu et al., 2004) . Following intravenous injection, pDNA was rapidly eliminated from the circulation and taken up by liver sinusoidal endothelial cells (Hisazumi et al., 2004) . These results suggest a potential of polynucleotides for an effective gene delivery system using a specific uptake mechanism. However, there are no reports on the development of nanoparticles using polynucleotides.
In the present study, we prepared ternary complexes using pDNA, polyethylenimine (PEI), and polynucleotide for a gene delivery system and evaluated their usefulness. 5 PEI is widely used as a polymeric vector. Polynucleotides with large molecular and relatively stable properties were used as coating materials, including polyadenylic acid (polyA), polyuridylic acid (polyU), polycytidylic acid (polyC), and polyguanylic acid (polyG). We newly found that ternary complexes coated by polyC were a useful candidate for the gene delivery system because of their high gene expression without toxicity. 6 
Materials and methods

Physicochemical property of ternary complexes
The particle sizes and ζ-potentials of complexes were measured using a Zetasizer Nano ZS (Malvern Instruments, Ltd., Malvern, United Kingdom). The number-fractioned mean diameter is shown.
To determine complex formations, 10 µL aliquots of complex solutions containing 1 µg pDNA were mixed with 2 µL loading buffer (30% glycerol and 0.2% bromophenol blue) and loaded onto a 0.8% agarose gel. Electrophoresis (i-Mupid J; Cosmo Bio, Tokyo, Japan) was carried out at 50 V in running buffer solution (40 mM Tris/HCl, 40 mM acetic acid, and 1 mM ethylenediaminetetraacetic acid (EDTA)) for 60 min. The retardation of pDNA was visualized with ethidium bromide staining.
Transfection experiments
The mouse melanoma cell line, B16-F10 cells, was obtained from the Cell Resource The complexes containing 1 µg pDNA in 100 µL Opti-MEM I medium were added to each well and incubated for 2 h. After incubation, the medium was replaced with 100 µL culture medium and incubated for another 22 h. Medium was replaced with 100 µL culture medium and 10 µL of the WST-1 reagent was added to each well. The cells were incubated for an additional 2 h at 37 °C, and absorbance was measured at a wavelength of 450 nm with a reference wavelength of 630 nm using a microplate reader.
The results are shown as a percentage of untreated cells.
Fluorescent microscopy
To visualize the uptake of the complexes and gene expressions, B16-F10 cells were transfected by various complexes constructed with pEGFP-C1, Rh-PEI, and polynucleotide. After 22 h incubation, the relative levels of Rh-PEI and GFP expression were characterized using fluorescent microscopy (200 × magnification;
BZ-9000; KEYENCE, Osaka, Japan).
Inhibition study
For determination of the endocytotic pathway, after 23 h pre-incubation, the cells were treated with 0.014 mM chlorpromazine (CPZ) as an inhibitor of clathrin-mediated endocytosis, 0.2 mM genistein as an inhibitor of caveolae-mediated endocytosis, or 1 mM amiloride as an inhibitor of macropinocytosis for 1 h. After treatment, the pDNA/PEI/polyC6 complexes and pDNA/PEI complexes were added to the medium containing each inhibitor and incubated for 2 h. After 2 h transfection, the medium was replaced with culture medium, cells were cultured for a further 22 h at 37 °C, and then the luciferase activities were determined.
For the inhibition study, the cells were transfected as described above with pDNA/PEI/polyC6 complexes in transfection medium containing various concentrations of polyC. After transfection, the medium was replaced with culture 12 medium, cells were cultured for a further 22 h at 37 °C, and then luciferase activities were determined.
Morphology of pDNA/PEI/polyC
Transmission electron microscopy (JEM-1230; JEOL, Tokyo, Japan) was used to observe the configuration of pDNA/PEI/polyC6.
Animals
Animal care and experimental procedures were performed in accordance with the Guidelines for Animal Experimentation of Nagasaki University with approval from the Institutional Animal Care and Use Committee. Male ddY mice (5-6 weeks old) were purchased from Japan SLC (Shizuoka, Japan). After shipping, mice were acclimatized to the environment for at least one day before experiments.
Agglutination study
Erythrocytes from mice were washed three times at 4 °C by centrifugation at 5000 rpm (Kubota 3500; Kubota, Tokyo, Japan) for 5 min and resuspended in PBS. A 2%
(v/v) stock suspension was prepared. Various complexes were added to the 13 erythrocytes (complexes: stock suspension = 1:1). The suspensions were incubated for 15 min at room temperature. The 10 µL suspensions were placed on a glass plate and agglutination was observed by microscopy (200 × magnification).
In vivo study
Each complex containing 40 µg pCMV-Luc at a volume of 300 µL per mouse was injected intravenously into mice to examine the transgene efficacy of pDNA/PEI and pDNA/PEI/polyC6 complexes. At 6 h following injection, the mice were sacrificed, and the liver, kidney, spleen, heart, and lung were dissected. The tissues were washed twice with cold saline and homogenized with lysis buffer. The homogenates were centrifuged at 15,000 rpm (Kubota 3500; Kubota) for 5 min and the supernatants were used for luciferase assays. Luciferase activity was indicated as RLU per gram of tissue.
To evaluate the acute toxicity of pDNA/PEI and pDNA/PEI/polyC6 complexes, each complex containing 200 µg pCMV-Luc at a volume of 1.5 mL per mouse was injected intravenously into mice. Twenty-four hours after administration, surviving mice were counted. 14 
Statistical analysis
Statistical significance between two groups was identified by Student's t test.
Multiple comparisons among groups were made by Dunnett's pairwise multiple comparison t test.
Results
Physicochemical characteristics and gel retardation assay
The particle size and ζ-potential of various complexes are shown in Table 1 . The pDNA/PEI complexes had 46.6 ± 5.5 nm particle size and 47.0 ± 0.5 mV ζ-potential.
The pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes with a charge ratio of polynucleotide to pDNA greater than 4 were less than 100 nm particle size, although pDNA/PEI/polyG complexes showed aggregation and particle size was not detected. Addition of polynucleotides decreased the ζ-potential of pDNA/PEI complexes concentration-dependently. The pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes with a charge ratio greater than 4 showed an anionic surface charge.
Complex formations were examined by a gel retardation assay ( Fig. 1) . Naked pDNA was detected as a band on agarose gel. The complexes showed no band of pDNA, which was released.
On the basis of the results of physicochemical properties, we performed further studies using the pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes. 16 
In vitro transfection efficiency
The complexes were incubated with B16-F10 cells and luciferase activity in the cells was determined. The in vitro transgene efficiencies of the complexes at various charge ratios are shown in Fig. 2 . The pDNA/PEI complexes exceeded 10 10 RLU/mg protein in transgene efficiency. Addition of polynucleotides to pDNA/PEI complexes decreased luciferase activities with an increase of the amount. The pDNA/PEI/polyC complexes retained high gene expression over 10 9 RLU/mg protein, although pDNA/PEI/polyA complexes and pDNA/PEI/polyU complexes showed low gene expression of less than 10 9 RLU/mg protein.
Cellular toxicity
Each complex was added to B16-F10 cells and cell viability was evaluated by WST-1 assay (Fig. 3) . The pDNA/PEI complexes showed significantly higher cellular toxicity than the control (P < 0.01). On the other hand, no cellular toxicity was observed in the pDNA/PEI/polyA complexes. The pDNA/PEI/polyU complexes showed moderate cytotoxicity concentration-dependently. The addition of polyC decreased the cytotoxicity of pDNA/PEI complexes, and the pDNA/PEI/polyC complexes with a charge ratio greater than 6 did not affect the cell viability of B16-F10 cells.
Fluorescent microscopy
The cellular uptake and gene expression were visualized in the pDNA/PEI/polyA6, pDNA/PEI/polyU6, and pDNA/PEI/polyC6 complexes. B16-F10 cells were transfected with the complexes containing Rh-PEI and pEGFP-C1 (Fig. 4) .
The pDNA/PEI complexes and pDNA/PEI/polyC6 complexes showed red dots of Rh-PEI in the cells. The bright green fluorescence of GFP was observed in the cells transfected with pDNA/PEI complexes and pDNA/PEI/polyC6 complexes, although no fluorescence was observed in pDNA/PEI/polyA6 complexes and pDNA/PEI/polyU6 complexes.
Inhibition study
The gene expression of pDNA/PEI/polyC6 complexes in medium containing various concentrations of polyC is shown in Fig. 5A . PolyC significantly inhibited the transgene efficiency of pDNA/PEI/polyC6 complexes concentration-dependently. 
The effect of serum on the transgene efficiency
The effect of serum on transgene efficiencies of the complexes was examined.
pDNA/PEI/polyC complexes were unaffected by serum. On the other hand, the transfection effect of pDNA/PEI complexes was decreased by serum ( Fig. 6 ).
Morphology of pDNA/PEI/polyC
pDNA/PEI/polyC6 complexes was observed as clumped nano-particles in the TEM (Fig. 7) .
In vivo study
In vivo transgene efficiency of pDNA/PEI complexes and pDNA/PEI/polyC6 complexes, which showed high transgene efficiency in an in vitro experiment, was 19 examined in ddY male mice and is shown in Fig. 8 . Luciferase activities in several tissues were determined 6 h after intravenous administration of the complexes. The pDNA/PEI complexes showed high gene expression in all tissues. On the other hand, pDNA/PEI/polyC6 complexes showed high gene expression selectively in the spleen.
In vivo acute toxicity and agglutination study
In vivo acute toxicity of pDNA/PEI and pDNA/PEI/polyC6 complexes was evaluated by the survival rate 24 h after intravenous infection of the complexes to ddY male mice.
All mice survived the injection of pDNA/PEI/polyC6 complexes, although 4 of 9 mice died after injection of pDNA/PEI complexes (Fig. 9A ).
Agglutination activities of pDNA/PEI/polyC6 complexes were compared to pDNA/PEI complexes in erythrocytes (Fig. 9B ). The pDNA/PEI/polyC6 complexes showed no agglutination, although the pDNA/PEI complexes agglutinated many erythrocytes. 20 
Discussion
Advances in the field of non-viral gene therapy have been the subject of intensive research because of the inherent safety issues associated with most viral vectors. Here, we hypothesized that anionic polymer-coating of complexes of pDNA and PEI could improve toxicity of PEI. Among anionic polymers, polynucleotides were expected to transfer the complexes into the targeted cells through a specific uptake mechanism. PolyA, polyU, polyC, and polyG were used as a coating material with large molecular weight and relatively stable properties.
We checked the physicochemical properties of the ternary complexes. Table 1 shows the particle size and ζ-potential of the complexes. The pDNA/PEI/polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes with a charge ratio greater than 4
showed less than 100 nm particle size and a negative surface charge; indicating the particle sizes of the ternary complexes were suitable for in vivo gene delivery. The negative surface charge of the ternary complexes suggested that polynucleotides effectively coated the particles. Furthermore, the size and ζ-potential of pDNA/PEI/ polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes were not changed in serum (data not shown); thus, stability of the ternary complexes was expected to be good enough for in vivo applications. Some polyanions such as heparin are known to release pDNA from pDNA/PEI complexes (Moret et al., 2001) . However, we found that the addition of polynucleotides did not push pDNA out of particles ( Fig. 1) .
Furthermore, the presence of serum did not promote pDNA release from the ternary complexes (data not shown). These results support that pDNA/PEI/ polyA, pDNA/PEI/polyU, and pDNA/PEI/polyC complexes are stable as self-assembled nano-particles without de-complexation, even in blood.
The in vitro transgene efficiency was evaluated with B16-F10 cells by luciferase activity (Fig. 2) . The pDNA/PEI complexes exceeded 10 10 RLU/mg protein in transgene efficiency. Addition of polynucleotides to pDNA/PEI complexes decreased luciferase activities concentration-dependently. These results reflect the low interaction of the negative surface charge of complexes with the cellular surface (Chen et al., 2011; Fröhlich, 2012) . In particular, the pDNA/PEI/polyA complexes and pDNA/PEI/polyU complexes showed low gene expression after the addition of polynucleotides. In fact, cellular uptake of Rh-PEI was not observed in the pDNA/PEI/polyA complexes and pDNA/PEI/polyU complexes at a charge ratio of 6 ( Fig. 4) . On the other hand, the pDNA/PEI/polyC complexes retained high gene expression over 10 9 RLU/mg protein and showed cellular uptake of Rh-PEI and gene expression of GFP. These results suggest that the uptake mechanism of pDNA/PEI/polynucleotide complexes differs with the type of polynucleotide and that there is a specific uptake mechanism of pDNA/PEI/polyC complexes.
pDNA/PEI/polyC complexes must release DNA so that it can be transported into the nucleus, although the detailed mechanism is unclear.
We therefore performed an inhibition study with polyC and various endocytotic inhibitors. The gene transfection of pDNA/PEI/polyC6 complexes was inhibited by polyC concentration-dependently. These results strongly indicate the specific uptake mechanism of pDNA/PEI/polyC complexes. CPZ, genistein, and amiloride all suppressed the transgene expression efficiency of the pDNA/PEI/polyC6 complexes, suggesting that it was taken up by the cells via several mechanisms. Among inhibitors, genistein especially suppressed the gene expression of pDNA/PEI/polyC6 complexes.
These results showed that the pDNA/PEI/polyC6 complexes were mainly taken up by caveolae-mediated endocytosis. It is generally believed that caveolar uptake does not lead to lysosomal degradation (Harris et al. 2002; Ferrari et al., 2003) . Therefore, pDNA/PEI/polyC6 complexes seem to be advantageous in terms of DNA delivery. On the other hand, the transgene expression efficiency of the pDNA/PEI complexes was only suppressed by genistein. These results suggested that the uptake mechanism of pDNA/PEI/polyC complexes differed from that of pDNA/PEI complexes.
We confirmed that the particle size of pDNA/PEI/polyC6 complexes was suitable for in vivo gene delivery using TEM (Fig. 7) . Then, in vivo transgene efficiency of pDNA/PEI/polyC6 complexes, which showed high transgene efficiency and low cytotoxicity in vitro (Figs. 2 and 3) , was examined in ddY male mice ( Fig. 8 ). Naked pDNA did not show gene expression in any tissues (data not shown). The pDNA/PEI/polyC6 complexes showed high gene expression selectively in the spleen, although pDNA/PEI complexes showed gene expression non-selectively in all tissues.
The positive charges of polyplexes are known to strongly interact with the negative surface of the cellular membrane and be taken up by endothelial cells through endocytosis. The strong positive charge of pDNA/PEI complexes may contribute to the high gene expression in all tissues. On the other hand, the high gene expression in the spleen of pDNA/PEI/polyC complexes may result in the low serum effect (Fig. 6 ).
The spleen plays important roles in regard to erythrocytes and the immune system (Cesta, 2006; Zandvoort et al., 2002) , acting primarily as a blood filter and having many macrophages and dendritic cells, which express many types of receptors that mediate the endocytosis of a broad range of polyanionic molecules. A specific uptake mechanism of pDNA/PEI/polyC complexes was strongly suggested in the present study; therefore, pDNA/PEI/polyC complexes may show specifically high transgene efficiency in the spleen. A splenic gene delivery system must be a promising approach for DNA vaccination. We have already demonstrated that a splenic gene delivery system markedly inhibited malaria infection in mice (Cherif et al., 2011 ).
There were mainly two types of cytotoxicity in the process of PEI-mediated cell transfection; immediate toxicity associated with free PEI and delayed toxicity associated with cellular processing of pDNA/PEI complexes (Godbey et al., 2001) . The pDNA/PEI complexes showed significant cellular toxicity (Fig. 3) . On the other hand, the ternary complexes reduced cytotoxicity. The negative surface charge of the polynucleotide-coating complexes may result in their safety because of low interaction with the cellular membrane. When administered into the circulatory system, the free PEIs interacted with negatively charged serum proteins and red blood cells, precipitated in huge clusters and adhered to the cellular surface (Lv et al. 2006 ). This effect could destabilize the plasma membrane and induce immediate toxicity. In fact, the pDNA/PEI complexes showed severe agglutination with erythrocytes. Four of 9 mice had died 24 h after injection of pDNA/PEI complexes at a 5-fold dose; however, pDNA/PEI/polyC6 complexes showed no agglutination with erythrocytes and acute toxicity ( Fig. 9 ). These results indicate the high safety of pDNA/PEI/polyC complexes compared to pDNA/PEI complexes.
Conclusion
In this study, we developed polynucleotide-coating complexes as a novel vector for clinical gene therapy. This vector consisted of stable particles with apparently negative ζ-potential. In particular, the pDNA/PEI/polyC6 complexes showed high in vitro gene expression without cytotoxicity. The inhibition study suggested the specific uptake mechanism of pDNA/PEI/polyC6 complexes. The pDNA/PEI/polyC6 complexes showed selective in vivo gene expression in the spleen, showing neither agglutination with erythrocytes nor acute toxicity. The pDNA/PEI/polyC6 complexes are a useful candidate for a gene delivery system. Further studies are necessary to reveal the detail uptake pathway of polyC. were transfected with each complex containing pCMV-Luc in culture medium. 35 Twenty-two hours after transfection, luciferase activity was evaluated. Each bar represents the mean ± S.E. of three experiments. 
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